Brief: Genedx Reports Fourth Quarter And Full Year 2022 Financial Results And Business Highlights
14/03/2023 22:48
March 14 (Reuters) - GeneDx Holdings Corp WGS.O :
* GENEDX REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* GENEDX HOLDINGS CORP SEES FY REVENUE $205.0 MILLION TO
$220.0
MILLION
* GENEDX HOLDINGS CORP - FULLY FUNDED TO EXPECTED
PROFITABILITY IN
2025
Source text for Eikon: ID:nGNXb623v4
Further company coverage: WGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GeneDx Holdings
See all newsBrief: Genedx Launches New Online Offering For Families To Improve Accessibility Of Exome Testing For Children
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
GeneDx Q2 revenue beats analyst estimates
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
Brief: Genedx Names Mark Gardner President To Lead Its Next Phase Of Scale And Growth